Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
357-367
Author(s):
Andrea D. Basso and Ronald J. Doll
Molecular Aspects of Stromal-Parenchymal Interactions in Malignant Neoplasms
Journal:
Current Molecular Medicine
Volume:
6
Page:
685-693
Author(s):
Attila Zalatnai
Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3411-3421
Author(s):
Y. Matsuzaki and A Honda
Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
451-460
Author(s):
Agostino Molteni, Sue Heffelfinger, John E. Moulder, Bruce Uhal and William J. Castellani
Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
217-222
Author(s):
Malini Olivo, Hong-Yan Du and Boon-Huat Bay
Sorafenib (BAY 43-9006): Review of Clinical Development
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
223-228
Author(s):
Raymond Ng and Eric X. Chen
Chronopharmacology and Antimicrobial Therapeutics
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
265-275
Author(s):
Marcela Rebuelto
Cytotoxic Potential of Phenothiazines
Journal:
Current Drug Targets
Volume:
7
Page:
1055-1066
Author(s):
Noboru Motohashi, Masami Kawase, Kazue Satoh and Hiroshi Sakagami
Expression, Distribution and Regulation of Phosphodiesterase 5
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3439-3457
Author(s):
Ching-Shwun Lin, Guiting Lin, Zhong-Cheng Xin and Tom F. Lue
STAT3: A Molecular Target for Cancer Whose Time Has Come
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
239-253
Author(s):
Beverly E. Barton